Controversy-free stem cells?

Researchers demonstrate feasibility of altered nuclear transfer to produce ES cells

Written byClementine Wallace
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Researchers have used altered nuclear transfer (ANT) to generate pluripotent murine embryonic stem (ES) cells from blastocysts inherently unable to implant in the uterus. Scientists hope the findings, published in the October 16 issue of Nature, will provide ES cell researchers with a technique that sidesteps the destruction of embryos, triggering ethical controversies.

"This is just one possible approach using ANT, but this study provides the scientific basis for the conversation that could lead us to resolve our nation's impasse over ES cell research," William Hurlbut, from Stanford University, Ca., told The Scientist. Hurlbut was the first to conceive of the idea of ANT, but did not participate in the study.

In another study, published in the same issue of Nature, researchers report using a cell biopsy technique for diagnosing genetic defects to extract ES cells without diminishing the embryo's viability, another technique they hope will help overcome the ethical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies